Pharma news
Pharma
For those who can draw an informative patent map and work out a good navigational route through the complexities, there is an opportunity to gain significant competitive advantages through making the right partnerships, argue Quentin Tannock and Anna Duch. 4 September 2014
Pharma
Law firm Simmons & Simmons has expanded its Düsseldorf office with the addition of a new partner. 3 September 2014
Pharma
English High Court Justice Philip James Sales has found a patent covering AstraZeneca’s bestselling drug Symbicort invalid after a challenge by Israeli generic drug maker Teva. 3 September 2014
Pharma
Novartis Pharmaceuticals has launched a lawsuit against generics company Zydus Noveltech and its subsidiaries, accusing them of infringing patents relating to a drug used to treat Alzheimer’s and Parkinson’s disease. 28 August 2014
Americas
Anglo-Swedish pharmaceutical company AstraZeneca has sued India-based Zydus for infringing three patents related to its heartburn drug Nexium (esomeprazole magnesium). 4 August 2014
Pharma
Parties need to take care when considering interim injunctions and keep an eye on future IP litigation, says Jan Lindberg. 1 August 2014
Pharma
UK-based pharmaceutical company AstraZeneca has boosted its patent portfolio with the acquisition of rights to Spanish company Almirall’s lung drugs, including Eklira (aclidinium). 30 July 2014
Americas
The expiration of US pharmaceutical company Pfizer’s patent for Viagra in many European countries was a contributing factor to the drop in revenue that it reported yesterday (July 29) when releasing its second-quarter earnings data. 30 July 2014
Americas
Law firm Dechert LLP has bolstered its life sciences team with the hire of Scott Warren as a partner in its IP practice in New York. 25 July 2014
Americas
A 17 percent fall in Eli Lilly’s second-quarter revenue to $4.94 billion, reported today (July 24), was driven by the expiry of US patents covering antidepressant Cymbalta (duloxetine hydrochloride) and osteoporosis drug Evista (raloxifene hydrochloride), the company said. 24 July 2014